Nieves Martínez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared on X:
“Reduced oxaliplatin exposure GI cancers Meta-analysis
- 24 studies (N=30,395)
- No significant survival difference
- G≥3 neuropathy OR 0.34
- G≥3 AEs OR 0.67
Less oxaliplatin may improve the therapeutic index without survival loss.
Read the full article.”
Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis
Authors: Wallace Klein Schwengbera, Fares Jamalb, Luis Felipe Leite da Silvac, Diana Segoviab, Abdullah Alsulaimanb, Ayla Koulib, Oluseyi Abidoyeb, Khalid Benkhadraa, Tanios Bekaii-Saabb, Mohamad Bassam Sonbol
Other articles featuring Nieves Martínez Lago on OncoDaily.